The Future of Personalized Health: 23andMe

Anne has built 23andMe into one of the world’s largest databases of genetic information, and her team has created a community around sharing that information, as well as recruiting participants to many genome-wide studies at once. Anne joined us last year for 3 CEOs, but this time she’s back to talk about how 23andMe and their most recent acquisition, CureTogether, can empower consumers by giving them access to their genetic information and crowd-sourced treatment reviews.

The Future of Personalized Health

The tools, devices, sensors and other technologies that will be used to collect and monitor health data and customize it to the user. Going forward, how will genomics, robotics and behavior change fit into personalized health?

The Future of Research – Part 2

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisions made by providers and consumers in everyday practice.

The Future of Research

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisions made by providers and consumers in everyday practice.

23andme – Personal Genome Analysis

Marisa Nelson demonstrates 23andme, a direct-to-consumer DNA testing service that allows anyone to analyze and learn about their personal genome. Learn how 23andme is tapping into patient advocacy groups and the ever-growing world of online communities to expand the research pool for rare diseases.

Interview with Anne Wojcicki

We talked with Anne Wojcicki, CEO at 23andme, about the biggest challenges, trends and developments in health care technology at the Health 2.0 San Francisco 2011 Fall Conference.

23andme – Relative Finder

Marisa Nelson, Business Development Associate, 23andme
23andme has shown many times at our conferences, bringing a new exciting functionality each time. This go round it’s the 23andme Relative Finder, which allows 23andme subscribers to compare their DNA against others using the service and find lost relatives.

Genomics, Proteomics, and DIY DNA

The “Getting to Know You: Genomics Proteomics and DIY DNA” panel took place as part of the Health 2.0 San Francisco 2011 Fall conference and highlighted DNA Guide, 23andme, OpenPCR, and DNA Direct by Medco as some of the most exciting products that can help us understands what’s going on in our genome.

Anne Wojcicki @ 3 CEOs

Anne Wojcicki, Co-Founder and CEO, 23andme
Anne built 23andMe into one of the world’s largest databases of genetic information, and her team has created a community around sharing that information, as well as recruiting participants to many genome-wide studies at once. We’ve featured 23andme several times at Health 2.0 but this is the first time Anne’s been on stage with us.

Anne is interviewed by Russ Mitchell, Kaiser Health News. These days Russ focuses on Health IT for Kaiser Health news, but he’s worked for virtually every business and IT focused publication out there, including Wired, Business 2.0 and US News & World report.

fopanne

The Future of Personalized Health: 23andMe

Anne has built 23andMe into one of the world’s largest databases of genetic information, and her team has created a community around sharing that information, as well as recruiting participants to many genome-wide studies at once. Anne joined us last year for 3 CEOs, but this time she’s back to talk about how 23andMe and their most recent acquisition, CureTogether, can empower consumers by giving them access to their genetic information and crowd-sourced treatment reviews.

fop

The Future of Personalized Health

The tools, devices, sensors and other technologies that will be used to collect and monitor health data and customize it to the user. Going forward, how will genomics, robotics and behavior change fit into personalized health?

thumbnail_2_9d8c0f2e_v5

The Future of Research – Part 2

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisio ...
thumbnail_2_902d6044_v19

The Future of Research

The emergence of user-generated content, and the rise of patient involvement in Health 2.0 is radically changing research in both discovery and clinical practice. It’s raising important questions. What is peer review? What is evidence? And what’s appropriate methodology in a world in which data are being generated and released from so many diverse sources so quickly? We’ll be looking across the spectrum from genomics to clinical trial recruiting all the way to clinical research and decisio ...
thumbnail_2_571355f_v5

23andme – Personal Genome Analysis

Marisa Nelson demonstrates 23andme, a direct-to-consumer DNA testing service that allows anyone to analyze and learn about their personal genome. Learn how 23andme is tapping into patient advocacy groups and the ever-growing world of online communities to expand the research pool for rare diseases.

thumbnail_2_1f11c4b3_v41

Interview with Anne Wojcicki

We talked with Anne Wojcicki, CEO at 23andme, about the biggest challenges, trends and developments in health care technology at the Health 2.0 San Francisco 2011 Fall Conference.

thumbnail_2_f5f942d_v1

23andme – Relative Finder

Marisa Nelson, Business Development Associate, 23andme
23andme has shown many times at our conferences, bringing a new exciting functionality each time. This go round it’s the 23andme Relative Finder, which allows 23andme subscribers to compare their DNA against others using the service and find lost relatives.

thumbnail_2_8bd87776_v1

Genomics, Proteomics, and DIY DNA

The “Getting to Know You: Genomics Proteomics and DIY DNA” panel took place as part of the Health 2.0 San Francisco 2011 Fall conference and highlighted DNA Guide, 23andme, OpenPCR, and DNA Direct by Medco as some of the most exciting products that can help us understands what’s going on in our genome.

Screen shot 2011-11-22 at 12.50.00 PM

Anne Wojcicki @ 3 CEOs

Anne Wojcicki, Co-Founder and CEO, 23andme Anne built 23andMe into one of the world’s largest databases of genetic information, and her team has created a community around sharing that information, as well as recruiting participants to many genome-wide studies at once. We’ve featured 23andme several times at Health 2.0 but this is the first time Anne’s been on stage with us. Anne is interviewed by Russ Mitchell, Kaiser Health News. These days Russ focuses on Health IT ...